These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 30409319

  • 1. Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.
    Kim M, Kim HK, Kim HI, Kim EH, Jeon MJ, Yi HS, Kim ES, Kim H, Kim TH, Kim BH, Kim TY, Kang HC, Kim WB, Chung JH, Shong YK, Kim SW, Kim WG.
    Oral Oncol; 2018 Nov; 86():48-52. PubMed ID: 30409319
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH, Bae MR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.
    Kim HI, Kim K, Park SY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Ahn HS, Kim SW, Kim TH, Chung JH.
    Oral Oncol; 2018 Mar; 78():80-86. PubMed ID: 29496063
    [Abstract] [Full Text] [Related]

  • 8. The proposed modification of TNM staging and therapeutic strategy for skip metastasis in papillary thyroid carcinoma: A multicenter retrospective cohort study.
    Yang Z, Heng Y, Zhao Q, Hao D, Tao L, Deng X, Cai W, Qiu W.
    Cancer Med; 2023 Jun; 12(12):13270-13278. PubMed ID: 37140212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size.
    Kim HI, Kim TH, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Jang HW, Kim YN, Kim H, Ahn HS, Kim K, Kim SW, Chung JH.
    Cancer Med; 2017 Oct; 6(10):2244-2251. PubMed ID: 28857489
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME.
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.
    Kim M, Kim WG, Oh HS, Park S, Kwon H, Song DE, Kim TY, Shong YK, Kim WB, Sung TY, Jeon MJ.
    Thyroid; 2017 Sep; 27(9):1149-1155. PubMed ID: 28635571
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis.
    Qin C, Cai S, Qi Y, Liu M, Xu W, Yin M, Tang H, Ji Q, Liao T, Wang Y.
    Front Endocrinol (Lausanne); 2024 Sep; 15():1453601. PubMed ID: 39175578
    [Abstract] [Full Text] [Related]

  • 15. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
    Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME.
    JAMA Otolaryngol Head Neck Surg; 2018 Feb 01; 144(2):108-114. PubMed ID: 29192312
    [Abstract] [Full Text] [Related]

  • 16. Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.
    Machens A, Dralle H.
    J Clin Endocrinol Metab; 2012 Dec 01; 97(12):4375-82. PubMed ID: 23019347
    [Abstract] [Full Text] [Related]

  • 17. Level V Metastasis, a Novel Predicative Factor for Recurrence in N1b Papillary Thyroid Carcinoma.
    Wu Y, Li J, Wu X, Dai L.
    Curr Pharm Des; 2018 Dec 01; 24(5):559-563. PubMed ID: 28990528
    [Abstract] [Full Text] [Related]

  • 18. Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.
    Zhang J, Gong J, Liu H, Zhou W, Cai M, Zhang C.
    BMC Cancer; 2024 Aug 22; 24(1):1039. PubMed ID: 39174906
    [Abstract] [Full Text] [Related]

  • 19. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N, Oyekunle TO, Zambeli-Ljepović A, Kazaure HS, Roman SA, Menegaux F, Sosa JA.
    Br J Surg; 2019 Jun 22; 106(7):889-897. PubMed ID: 31012500
    [Abstract] [Full Text] [Related]

  • 20. Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma.
    Bertin JB, Buffet C, Leenhardt L, Menegaux F, Chereau N.
    Langenbecks Arch Surg; 2022 Nov 22; 407(7):3025-3030. PubMed ID: 35819485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.